Among the EU Member States there are a range of different policies with respect to making influenza vaccines available to the general public — often they are specifically targeted at older groups of people or other at-risk groups. In the EU in 2017, more than two fifths of those aged 65 and over were vaccinated against influenza.
Researchers’ hopes are raised after a trial using monoclonal antibodies to prevent pneumonia in ventilated intensive care patients gets good results.
The European Innovation Council (EIC) pilot partnered with TechTour for five exclusive online pitching sessions on Healthtech, Digital Technologies and CleanTech. Between 11-13th November, 40 companies funded by the EIC Pilot participated in the TechTour ePitch, but only 10 winners were selected. The finalists will compete at the finals in the European Venture Contest in Essen, on the 9-10 December.
Today the European Commission published the reports that depict the profile of health systems in 30 countries. Country Health Profiles are being issued with the Companion Report that shows some of the biggest trends in the transformation of the healthcare systems and draws key conclusions from the Profiles.
Update: the minutes of the meeting are now available.
On 11 November 2019, the European Commission adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.V. for a vaccine against Ebola. This vaccine, called Ervebo, had been in development since the Ebola outbreak in West Africa in 2014. It is already used, as part of a specific protocol, to protect people at risk of infection, such as healthcare workers or people who have been exposed to infected persons.
The monitoring report is based on measles and rubella data from The European Surveillance System (TESSy) for 1 October 2018 to 30 September 2019. Twenty-nine countries reported measles data for September 2019, of which 280 cases were reported by 17 countries; 12 countries reported no cases. Overall, case numbers continued to decrease compared with the previous two months. Romania and France had the highest case counts with 112 and 56 cases, respectively. Notable decreases were reported in France, Italy, the United Kingdom and Lithuania.